Literature DB >> 28861212

Revised disproportionality analysis of Mirena and benign intracranial hypertension.

Mahyar Etminan1.   

Abstract

Entities:  

Year:  2017        PMID: 28861212      PMCID: PMC5557162          DOI: 10.1177/2042098617709768

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


× No keyword cloud information.
  5 in total

1.  OpenVigil--free eyeballs on AERS pharmacovigilance data.

Authors:  Ruwen Böhm; Jan Höcker; Ingolf Cascorbi; Thomas Herdegen
Journal:  Nat Biotechnol       Date:  2012-02-08       Impact factor: 54.908

2.  Risk of intracranial hypertension with intrauterine levonorgestrel.

Authors:  Mahyar Etminan; Hao Luo; Paul Gustafson
Journal:  Ther Adv Drug Saf       Date:  2015-06

3.  Risk of intracranial hypertension with intrauterine levonorgestrel: reply.

Authors:  Mahyar Etminan
Journal:  Ther Adv Drug Saf       Date:  2016-02

4.  Practice tips. Inserting the levonorgestrel intrauterine system: off-label use.

Authors:  Catherine Caron
Journal:  Can Fam Physician       Date:  2007-04       Impact factor: 3.275

Review 5.  Epidemiology and risk factors for idiopathic intracranial hypertension.

Authors:  John Chen; Michael Wall
Journal:  Int Ophthalmol Clin       Date:  2014
  5 in total
  1 in total

1.  Pseudotumor Cerebri Following Nexplanon® Implantation.

Authors:  Benjamin E Jewett; Rick L Wallace; Olga Sarkodie
Journal:  Cureus       Date:  2018-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.